1. bookAHEAD OF PRINT
Journal Details
License
Format
Journal
First Published
30 Mar 2015
Publication timeframe
4 times per year
Languages
English
access type Open Access

Carnitine Palmitoyltransferase-II Deficiency: Case Presentation and Review of the Literature

Published Online: 12 Jun 2021
Page range: -
Received: 20 May 2021
Journal Details
License
Format
Journal
First Published
30 Mar 2015
Publication timeframe
4 times per year
Languages
English
Abstract

Carnitine palmitoyltransferase-II deficiency, an autosomal recessive disorder, is the most common cause of recurrent rhabdomyolysis in adults. Recognition and avoidance of triggers, such as heavy exercise and stress, is key in prevention of further episodes; however, even with preventative measures, many patients will continue to experience periodic symptoms, including rhabdomyolysis. Avoidance of renal failure, correction of electrolyte disturbances and halting further muscle breakdown are the goals of treatment. It is essential for clinicians to recognize the signs and symptoms of acute disease in CPT-II deficiency. We present a case of recurrent rhabdomyolysis requiring hospitalization in a patient with CPT-II deficiency and review the literature for common clinical manifestations, diagnostics, and treatment strategies.

Keywords

1. JOSHI PR, ZIERZ S. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach. Molecules.2020;25(8).Search in Google Scholar

2. WEIBRECHT K, DAYNO M, DARLING C, BIRD SB. Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury. J Med Toxicol. 2010;6(3):294-300.Search in Google Scholar

3. RAY L, NANDA SK, CHATTERJEE A, SARANGI R, GAGULY S. A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: Need for new reference ranges. Int J Appl Basic Med Res. 2015;5(1):31-5.Search in Google Scholar

4. BOSCH X, POCH E, GRAU JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62-72.Search in Google Scholar

5. WIESER T, DESCHAUER M, OLEK K, HERMANN T, ZIERZ S. Carnitine palmitoyltransferase II deficiency. Molecular and biochemical analysis of 32 patients. Neurology. 2003;60(8):1351-1353.Search in Google Scholar

6. NANCE JR, MAMMEN AL. Diagnostic evaluation of rhabdomyolysis. Muscle Nerve. 2015;51(6):793-810.Search in Google Scholar

7. JOSHI PR, DESCHAUER M, ZIERZ S. Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients. J Neurol Sci. 2014;338(1-2): 107-11.Search in Google Scholar

8. MANSPEAKER S, HENDERSON K, RIDDLE D. Treatment of exertional rhabdomyolysis in athletes: a systematic review. JBI Database System Rev Implement Rep. 2016;14(6):117-47.Search in Google Scholar

9. SOMAGUTTA MR, PAGAD S, SRIDHARAN P, NANTHAKUMARAN S, ARNOLD AA, MAY V et al., Role of Bicarbonates and Mannitol in Rhabdomyolysis: A Comprehensive Review. Cureus. 2020;12(8):e9742-e9742.Search in Google Scholar

10. ANTOON JW, CHAKRABORTI C. Corticosteroids in the treatment of alcohol-induced rhabdomyolysis. Mayo Clin Proc. 2011. 86(10):1005-7.Search in Google Scholar

11. SUMMERLIN ML, REGIER DS, FRASER JL, CHAPMAN KA, KAFASHZADEH D, BILLINGTON C et al., Use of dexamethasone in idiopathic, acute pediatric rhabdomyolysis. Am J Med Genet A. 2021;185(2):500-507.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo